Transparency of data on the value chain of medicines in Argentina, Brazil, and Colombia
Introduction: The transparency of data on the value chain of medicines is crucial for the study and monitoring of the pharmaceutical system. These data may impact medicine pricing negotiations, contribute to patient access to pharmaceutical products, and strengthen health systems.Objective: This stu...
Main Authors: | Alane Andrelino Ribeiro, Angela Acosta, Marcela Amaral Pontes, Manuel Alejandro Machado Beltran, Rafaela Tavares Peixoto, Silvana Nair Leite |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1063300/full |
Similar Items
-
Análise dos preços regulados e praticados para os medicamentos mais consumidos no Brasil*
by: Marcela Pontes, et al.
Published: (2024-02-01) -
Is Self-Regulation Sufficient? Case of the German Transparency Code
by: Kristin Buske, et al.
Published: (2016-02-01) -
Multi stakeholders of health and industries perspectives on medicine price transparency initiative in private health care settings in Malaysia
by: Nur Sufiza Ahmad, et al.
Published: (2020-07-01) -
The Effect of Intellectual Capital Efficiency and Informational Transparency on Cost of Equity Owners
by: Zahra Fotourehchi, et al.
Published: (2019-05-01) -
THE TRANSPARENCY IN THE REPORTING OF INTELLECTUAL CAPITAL: BETWEEN THE MANAGEMENT RESPONSIBILITY AND THE STAKEHOLDERS' REQUIREMENTS
by: Dicu Roxana-Manuela
Published: (2011-07-01)